| 000 | 01069 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513100942.0 | ||
| 264 | 0 | _c19961108 | |
| 008 | 199611s 0 0 eng d | ||
| 022 | _a0959-8138 | ||
| 024 | 7 |
_a10.1136/bmj.313.7059.735 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharp, S J | |
| 245 | 0 | 0 |
_aThe relation between treatment benefit and underlying risk in meta-analysis. _h[electronic resource] |
| 260 |
_bBMJ (Clinical research ed.) _cSep 1996 |
||
| 300 |
_a735-8 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMathematics |
| 650 | 0 | 4 | _aMeta-Analysis as Topic |
| 650 | 0 | 4 | _aMortality |
| 650 | 0 | 4 | _aRisk Assessment |
| 650 | 0 | 4 | _aSclerotherapy |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aThompson, S G | |
| 700 | 1 | _aAltman, D G | |
| 773 | 0 |
_tBMJ (Clinical research ed.) _gvol. 313 _gno. 7059 _gp. 735-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1136/bmj.313.7059.735 _zAvailable from publisher's website |
| 999 |
_c8813705 _d8813705 |
||